DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Droperidol Versus Metoclopramide for the Treatment of Primary Headaches

Information source: University of Iowa
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Primary Headaches (Includes Migraines, Tension, Cluster Headaches)

Intervention: Droperidol (Drug); Metoclopramide (Drug); Diphenhydramine (Drug)

Phase: N/A

Status: Terminated

Sponsored by: University of Iowa

Official(s) and/or principal investigator(s):
Jon Van Heukelom, MD, Principal Investigator, Affiliation: University of Iowa
Christopher Hogrefe, MD, Principal Investigator, Affiliation: University of Iowa
Brett Faine, PharmD, Principal Investigator, Affiliation: University of Iowa


The purpose of this study is to determine if droperidol is equally as effective as metoclopramide for treatment of primary headaches in the Emergency Department.

Clinical Details

Official title: Droperidol Versus Metoclopramide for the Treatment of Primary Headaches in the Emergency Department: A Prospective Randomized, Double-blinded Trial.

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Pain Scale

Secondary outcome:

Length of Stay

24 hour pain score

Adverse Effects


Minimum age: 18 Years. Maximum age: 64 Years. Gender(s): Both.


Inclusion Criteria:

- 18 years old to 65 years old, diagnosis of primary headache

Exclusion Criteria:

- Allergy to study medications, pregnant, breast-feeding, prisoners, non-english

speaking, not eligible to receive droperidol based on ED protocol (see below), patients in whom head trauma, infection, vascular disorders, and disorders of facial or cranial structures are suspected ED Droperidol Protocol Droperidol must NOT be used in patients with any of the following:

- Known or suspected QT prolongation, including congenital long QT syndrome

- Cardiac Disease [cardiomyopathy, congestive heart failure, hypertension, ischemic

heart disease, myocardial infarction, bradycardia (< 50 bpm)]

- History of the following:

- Renal failure

- Cerebrovascular disease

- Diabetes or hypoglycemia

- Alcoholism/alcohol abuse

- Pituitary insufficiency

- Hypothyroidism

- Hypothermia

- Anorexia

- Advanced age (>65 yrs)

- Use of the following medications: digoxin, benzodiazepine, diuretics, IV opiates, or

other medications known to prolong the QTc interval.

Locations and Contacts

University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, United States
Additional Information

Starting date: July 2011
Last updated: January 14, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017